Matthias Kleinz, executive vice president and head of translational sciences investments at UPMC Enterprises, explained why biopharma companies cannot ignore China anymore.
The impact of private equity investments in healthcare under the new administration is multifaceted. While deregulation and business-friendly policies could stimulate investment and drive innovation, there are significant concerns about the potential negative effects on healthcare quality and access.
By reducing administrative burden and redesigning workflows around human needs, it creates space for what matters most: connection between clinicians and patients.
According to a CB Insight's report, GV (formerly Google Ventures) funded the most digital health companies with 22 investments, making it most active investor in that sector for four years in a row.
Which capital funding options fit your healthcare or life science business?
GE is in the midst of spinning off several companies to generate cash as it undergoes a huge restructuring. Sources say it will include GE Ventures, the corporate venture capital arm of GE, that invests in healthcare as well as nonhealthcare startups.
You would be surprised to learn that a few health systems are reporting that they have high rate of adoption of technologies they have invested.
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.
That figure reflected investment across 77 digital health deals, dominated by disease diagnosis in terms of total investment and monitoring of disease in terms of deal volume.
Partners Innovation Fund II will invest in 15-20 companies, according to Roger Kitterman, Vice President of Partners Innovation. It will be particularly aggressive in gene therapy.
Aflac Corporate Ventures took part in the Series A round. Last month, the insurer announced plans to set up a $100 million fund to invest in early stage companies relevant to Aflac's core business.
Renee Ryan, vice president, venture investments at Johnson & Johnson's corporate venture capital arm, talks about what's exciting in healthcare, her favorite investments, and mistakes that entrepreneurs make.
Veradigm examines key clinical trends, comorbidity profiles, and treatment trends across adolescence, reproductive years, and peri-/post-menopause. Download it today!
A new report projects that the global medical devices industry is poised to see its first funding increase since 2014, news that is likely to cheer startups and entrepreneurs in the field.
Plus, an analysis of the Providence St Joseph Health merger and what the plans are for technology, patient safety and mental health and a look at some of the largest digital health investments outside the U.S.
Corporate venture capitalists are not only pumping more money to spur innovation, but they are going beyond traditional comfort zones.
Corporate venture investment has emerged as an important alternative to more traditional healthcare funding avenues. However, there's still a dearth of information about their activity.
Part II in our research examining which corporate venture capitalists you can trust and rely on.